Efficacy and Safety of Two Doses of HIL-214 in Children
Clinical trial NCT05281094 · TERMINATED
Trial details
- NCT number
- NCT05281094
- Sponsor
- HilleVax
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-28
- Primary completion
- 2023-12-28
- Enrollment
- 3084
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.